<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647535/bin/bjc2015188f2.jpg"/> </div> <div class="text-side"> <h1>Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.</h1> <p>Prominent nucleolar formation in 357 neuroblastomas of undifferentiated/poorly differentiated subtypes. (A) Bar graph shows case distribution by prominent nucleolar formation. Left: Tumours with prominent nucleolar formation, Right: Tumours without prominent nucleolar formation. MYCN(+)=MYCN protein(+) tumours (red); MYC(+)=MYC protein(+) tumours (purple); Both(+)=one tumour with both MYCN protein(+) and MYC protein(+) (yellow); UH=unfavourable histology tumours with MYCN protein(−) or (±) and MYC protein(−) or (±) (brown); FH=favourable histology tumours with MYCN protein(−) or (±) and MYC protein(−) or (±) (light blue). Tumours having prominent nucleoli are predominantly composed of MYCN protein(+) or MYC protein(+) neuroblastomas. (B) Panel shows histology of neuroblastoma with prominent nucleolar formation (upper) and without prominent nucleolar formation (lower). H&amp;E staining, original magnification × 1000.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26035700/" target="_blank">26035700</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>